Cys-LL-37 peptide
| Name | Cys-LL-37 | ||||||
| Sequence | CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| 3-letter-code | Cys - Leu - Leu - Gly - Asp - Phe - Phe - Arg - Lys - Ser - Lys - Glu - Lys - Ile - Gly - Lys - Glu - Phe - Lys - Arg - Ile - Val - Gln - Arg - Ile - Lys - Asp - Phe - Leu - Arg - Asn - Leu - Val - Pro - Arg - Thr - Glu - Ser | ||||||
| Notes | LL-37 with N-terminal Cystein. | ||||||
| Molecular weight | 4596.47 | ||||||
| Counter ion | TFA | ||||||
| Solubilization | Soluble in pure water. | ||||||
| Description | Synthetic peptide corresponding to aa 134-170 of the human cationic antimicrobial protein 18 (hCAP18), with a Cys added to the N-terminus. | ||||||
| References | Schmidtchen A, Frick IM, Andersson E, Tapper H, Björck L. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol. 2002 46(1):157-168. | ||||||
Order Cys-LL-37 peptide
| Amount | Cat.No. | Unit price | |||||
|---|---|---|---|---|---|---|---|
| 1 mg | SP-CLL37-1 | 470 EUR | BUY | ||||
| 5 mg | SP-CLL37-5 | 1520 EUR | BUY | ||||
| For larger amounts please inquire. | |||||||
Cys-LL-37 antibody
Please inquire for pricing and availability.Related peptides
| Name | Sequence | ||||||
|---|---|---|---|---|---|---|---|
| Cys-LL-37-Cys | CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC | ||||||
| LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 (acetate) | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 : Ultra-pure | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 Citrulline | LLGDFF(Cit )KSKEKIGKE FK(Cit)IVQ (Cit)IKDFL (Cit)NLVP( Cit)TES | ||||||
| LL-37 FK-13 | FKRIVQRIKDFLR | ||||||
| LL-37 FKR | FKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 GKE | GKEFKRIVQRIKDFLRNLVPR | ||||||
| LL-37 KRI | KRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 LLG | LLGDFFRKSKEKIGKEFKRIV | ||||||
| LL-37 RKS | RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 SKE | SKEKIGKEFKRIVQRIKDFLR | ||||||
| LL-37-Cys | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC | ||||||
